/> September 12, Step Pharmaceuticals issued a number of consecutive announcements, the announcement behind the frequent action - the same day announced the establishment of investment in a number of subsidiaries.
Haizheng Pharmaceuticals gave a controlling stake in its subsidiary of $3.828 billion or eased its $10 billion debt
Time of Update: 2021-03-04
strains high-volume screening platform. At present, more than 20 biological pharmaceutical products, of which 9 products have received major new drug creation special support. Haizheng Bolly's 2015 listing of Anjuno is the first single-resistant
Kyushua Pharmaceuticals' $790 million acquisition of Novaral's CDMO subsidiary is on fire!
Time of Update: 2021-03-04
Jiuzhou Pharmaceuticals announced on the evening of September 4 that it had signed an agreement with Novaral Investment to acquire a 100% stake in Suzhou Novarma after the divestiture of technology and pharmaceutical development assets
The sale of a stake in Harmony Hospital by Fosun Pharma's subsidiary has been completed
Time of Update: 2021-03-04
are the limited partnership interests of Harmony Hospitals and Clinics) and shares in Healthy Harmony GP, Inc. ("Healthy Harmony GP"), a managing partner of HHH. Of the approximately $523.15 million
Tiger Pharma: Subsidiary and Kyusek Pharmaceuticals established the United States FJ Company to provide drug research and development one-stop service
Time of Update: 2021-02-22
Tiger Pharma announced on the evening of January 24th that Frontage Laboratories, Inc., a subsidiary of the company, had announced that it would not be in a company that would be in a state of force. ("Fangda Pharmaceuticals") recently signed
The Chinese pharmaceutical subsidiary invested 91.45 million yuan to take a 51% stake in Chinese and Swiss medicine
Time of Update: 2021-02-19
announced that the current business of Chinese and Swiss medicine to public hospitals pharmaceutical distribution business, in the supply chain management, hospital pharmacy design, cooperation with hospitals, etc.
Guibao and Weishi subsidiary H3 reached a strategic joint:
Time of Update: 2021-02-12
's RNA cutting platform can provide a stronger response to cancer. collaboration will explore modulation RNA scissors that have developed potential first-in-class therapies that direct the immune system to target cancer cells and help more
People's Fu pharmaceutical subsidiary Anli Shengtan tablets to obtain drug registration approval notice
Time of Update: 2021-02-01
("Wuhan People's Fu"), a subsidiary of People's Fu Pharmaceutical Group Co., Ltd.
Lu anti-pharmaceutical subsidiary was certified as an injection drug of ammonia hydrochloride
Time of Update: 2021-01-20
On November 18, Lu Anti-Pharma announced that the holding subsidiary Shandong Lu Anti-Pharmaceutical Group Cyt Co., Ltd. recently received the State Drug Administration issued a hydrochloric acid bromoso injection "Drug Registration Certificate
Givetini tablets, a wholly owned subsidiary of Tiansli, obtained a drug registration certificate
Time of Update: 2021-01-15
% in patients in the subgroup. treatment of advanced lung cancer has limited efficacy, the prognosis is not optimistic. target drug with EGFR as the target of treatment significantly prolonged the survival time of disease-free progression, improved
Lu anti-pharmaceutical subsidiary was certified as an injection drug of ammonia hydrochloride
Time of Update: 2021-01-09
The hydrochloric acid bromoso injection is a generic drug developed independently by Shandong Lu Anti-Pharmaceutical Group Cyt Co., Ltd., and the adaptive disease is suitable for acute and chronic lung diseases with abnormal sputum secretion and poor sputum discharge function.
Another subsidiary of The Micro-Invascope Medical Spin-Off has recently been listed three times
Time of Update: 2021-01-06
Finishing: Chocolate Micro-Invasive Medical continued to split recently, Micro-Invasive Medical announced that it is considering a possible spin-off of the company's non-whowicial subsidiary Micro-Invasive (Shanghai) Medical Robotics Co., Ltd
Ossercon's subsidiary was the first to evaluate the use of Lansolazole for injections
Time of Update: 2021-01-03
subsidiaries submitted a supplementary application for conformity evaluation in January 2019 to complete the evaluation study on the quality consistency of injections of this product, and recently obtained the first notification of approval
Goliath subsidiary NASH Drug was approved by the FDA Fast Track
Time of Update: 2020-12-27
On December 14, 2020, Ganley, a wholly owned subsidiary of Goliath Pharmaceuticals, announced that the U.S. Food and Drug Administration (FDA) had granted fast-track qualification to the company's NASH candidate drug, ASC42. fda's fast-track
Watson, a low-priced HPV vaccine subsidiary, has attracted 怼 attention from investors
Time of Update: 2020-12-24
that Watson's shareholders are relatively dispersed, with the largest shareholder, Yunnan Industrial Investment Holdings Group Co., Ltd., holding only 4.97 percent and Chairman Li Yunchun holding 3.13 percent. In addition, the Hong Kong Central
Another subsidiary of The Micro-Invascope Medical Spin-Off has recently been listed three times
Time of Update: 2020-12-23
Orthopaedic Materials Co., Ltd. and independently listed on the Board. board announced at the time that Vico Orthopaedics had submitted an application to the Shanghai Stock Exchange for listing on the board. we have a wide range
